Skip to main content
Top
Published in: Journal of Nuclear Cardiology 4/2011

01-08-2011 | Editorial

Incremental prognostic value of coronary flow reserve assessed with single-photon emission computed tomography

Authors: Robert A. deKemp, PhD, Mikael Trottier, MD, FRCPC, Rob S. B. Beanlands, MD, FACC, FRCPC

Published in: Journal of Nuclear Cardiology | Issue 4/2011

Login to get access

Excerpt

The diagnostic and prognostic values of stress myocardial perfusion imaging (MPI) is well established with SPECT1-12 and more recently with PET or PET-CT imaging.13-15 Conventional MPI identifies local reductions in perfusion relative to the best ventricular wall, where the maximum value is presumed to be normal. However, this technique is known to underestimate the extent or severity of multi-vessel coronary disease, when the maximum value does not represent normally perfused myocardium.16,17 In contrast, myocardial perfusion measured on an absolute scale (mL/min/g) permits the assessment of stress-to-rest perfusion or vasodilator reserve without the assumption of a normal reference region, first demonstrated with PET imaging by Gould et al18 In this way, the stress perfusion scan is interpreted relative to the individual’s normal resting state, using the patient as their own control. The clinical value of absolute perfusion or myocardial blood flow (MBF) measurements has been reported extensively using dynamic PET imaging with 15O-water and 13N-ammonia in patient populations such as diabetes, hypertension, hyperlipidemia, smoking, syndrome X, non-compaction, takotsubo, hypertrophic ,and dilated cardiomyopathies. The impact of invasive fractional flow reserve (FFR) imaging to direct PCI and improve patient outcome has recently been reported using FFR measurements in a prospective randomized controlled trial.19
Literature
1.
go back to reference Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: What is the warranty period of a normal scan? J Am Coll Cardiol 2003;41:1329-40.PubMedCrossRef Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: What is the warranty period of a normal scan? J Am Coll Cardiol 2003;41:1329-40.PubMedCrossRef
2.
go back to reference Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. J Am Coll Cardiol 2004;43:200-8.PubMedCrossRef Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. J Am Coll Cardiol 2004;43:200-8.PubMedCrossRef
3.
go back to reference Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995;26:639-47.PubMedCrossRef Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995;26:639-47.PubMedCrossRef
4.
go back to reference Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: Incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14.PubMed Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: Incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14.PubMed
5.
go back to reference Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43.PubMed Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43.PubMed
6.
go back to reference Shaw LJ, Berman DS, Hachamovitch R, et al. Noninvasive strategies for the estimation of cardiac risk: An observational assessment of outcome in stable chest pain patients. Am J Cardiol 2000;86:1-7.PubMedCrossRef Shaw LJ, Berman DS, Hachamovitch R, et al. Noninvasive strategies for the estimation of cardiac risk: An observational assessment of outcome in stable chest pain patients. Am J Cardiol 2000;86:1-7.PubMedCrossRef
7.
go back to reference Gibbons RJ, Hodge DO, Berman DS, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation 1999;23:2140-5. Gibbons RJ, Hodge DO, Berman DS, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation 1999;23:2140-5.
8.
go back to reference Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998;32:57-62.PubMedCrossRef Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998;32:57-62.PubMedCrossRef
9.
go back to reference Groutars RG, Verzijlbergen JF, Zwinderman AH, et al. Incremental prognostic value of myocardial SPET with dual-isotope rest 201Tl/stress 99mTc-tetrofosmin. Eur J Nucl Med 2002;29:46-52.CrossRef Groutars RG, Verzijlbergen JF, Zwinderman AH, et al. Incremental prognostic value of myocardial SPET with dual-isotope rest 201Tl/stress 99mTc-tetrofosmin. Eur J Nucl Med 2002;29:46-52.CrossRef
10.
go back to reference Groutars RG, Verzijlbergen JF, Muller AJ, et al. Prognostic value and quality of life in patients with normal rest thallium-201/stress technetium 99m-tetrofosmin dual-isotope myocardial SPECT. J Nucl Cardiol 2000;7:333-41.PubMedCrossRef Groutars RG, Verzijlbergen JF, Muller AJ, et al. Prognostic value and quality of life in patients with normal rest thallium-201/stress technetium 99m-tetrofosmin dual-isotope myocardial SPECT. J Nucl Cardiol 2000;7:333-41.PubMedCrossRef
11.
go back to reference Galassi AR, Azzarelli S, Tomaselli A, et al. Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected or known coronary artery disease. Am JCardiol 2001;88:101-6.CrossRef Galassi AR, Azzarelli S, Tomaselli A, et al. Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected or known coronary artery disease. Am JCardiol 2001;88:101-6.CrossRef
12.
go back to reference Shaw LJ, Hendel R, Borges-Neto S, Lauer MS, Alazraki N, et al. Prognostic value of normal exercise and adenosine 99mTc-tetrofosmin SPECT imaging: Results from the Multicenter Registry of 4,728 patients. J Nucl Med 2003;44:134-9.PubMed Shaw LJ, Hendel R, Borges-Neto S, Lauer MS, Alazraki N, et al. Prognostic value of normal exercise and adenosine 99mTc-tetrofosmin SPECT imaging: Results from the Multicenter Registry of 4,728 patients. J Nucl Med 2003;44:134-9.PubMed
13.
go back to reference Bateman TM, Heller GV, McGhie AI, Friedman JD, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: Comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol 2006;13:24-33.PubMedCrossRef Bateman TM, Heller GV, McGhie AI, Friedman JD, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: Comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol 2006;13:24-33.PubMedCrossRef
14.
go back to reference Yoshinaga K, Chow BJ, deKemp RA, Beanlands R, et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol 2006;48:1029-39.PubMedCrossRef Yoshinaga K, Chow BJ, deKemp RA, Beanlands R, et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol 2006;48:1029-39.PubMedCrossRef
15.
go back to reference Sampson UK, Di Carli MF, Dorbala S, Kwong R, et al. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol 2007;49:1052-8.PubMedCrossRef Sampson UK, Di Carli MF, Dorbala S, Kwong R, et al. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol 2007;49:1052-8.PubMedCrossRef
16.
go back to reference Parkash R, deKemp RA, Beanlands RS, et al. Potential utility of rubidium-82 PET quantification in patients with 3-vessel coronary artery disease. J Nucl Cardiol 2004;11:440-9.PubMedCrossRef Parkash R, deKemp RA, Beanlands RS, et al. Potential utility of rubidium-82 PET quantification in patients with 3-vessel coronary artery disease. J Nucl Cardiol 2004;11:440-9.PubMedCrossRef
17.
go back to reference Ziadi MC, deKemp RA, Williams K, Guo A, Renaud JM, Klien R, et al. Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? J Nucl Cardiol 2011 (submitted). Ziadi MC, deKemp RA, Williams K, Guo A, Renaud JM, Klien R, et al. Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? J Nucl Cardiol 2011 (submitted).
18.
go back to reference Goldstein RA, Kirkeeide RL, Demer LL, Merhige M, Nishikawa A, Smalling RW, et al. Relation between geometric dimensions of coronary artery stenoses and myocardial perfusion reserve in man. J Clin Invest 1987;79:1473-8.PubMedCrossRef Goldstein RA, Kirkeeide RL, Demer LL, Merhige M, Nishikawa A, Smalling RW, et al. Relation between geometric dimensions of coronary artery stenoses and myocardial perfusion reserve in man. J Clin Invest 1987;79:1473-8.PubMedCrossRef
19.
go back to reference Tonino PAL, De Bruyne B, Pijls NHJ, Siebert U, Ikeno F, van‘t Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Eng J Med 2009;360:213-24.CrossRef Tonino PAL, De Bruyne B, Pijls NHJ, Siebert U, Ikeno F, van‘t Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Eng J Med 2009;360:213-24.CrossRef
20.
go back to reference Tio R, van Veldhuisen DJ, Zijlstra F, Slart RH, et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 2009;50:214-9.PubMedCrossRef Tio R, van Veldhuisen DJ, Zijlstra F, Slart RH, et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 2009;50:214-9.PubMedCrossRef
21.
go back to reference Herzog BA, Husmann L, Kaufmann PA, et al. Long-term prognostic value of 13N-ammonia myocardial perfusion PET: Added value of coronary flow reserve. J Am Coll Cardiol 2009;54:150-6.PubMedCrossRef Herzog BA, Husmann L, Kaufmann PA, et al. Long-term prognostic value of 13N-ammonia myocardial perfusion PET: Added value of coronary flow reserve. J Am Coll Cardiol 2009;54:150-6.PubMedCrossRef
22.
go back to reference Ziadi MC, deKemp RA, Williams K, Guo A, Chow BJW, Renaud JM, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol 2011 (in press). Ziadi MC, deKemp RA, Williams K, Guo A, Chow BJW, Renaud JM, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol 2011 (in press).
23.
go back to reference Stephania D, Nappi C, Acampa W, Storto G, Pellegrino T, Ricci F, et al. Incremental prognostic value of coronary flow reserve assessed with single photon emission computed tomography. J Nucl Cardiol 2011. doi:10.1007/s12350-011-9345-4. Stephania D, Nappi C, Acampa W, Storto G, Pellegrino T, Ricci F, et al. Incremental prognostic value of coronary flow reserve assessed with single photon emission computed tomography. J Nucl Cardiol 2011. doi:10.​1007/​s12350-011-9345-4.
24.
go back to reference Uren NG, Camici PG, Melin JA, Bol A, de Bruyne B, Radvan J, et al. Effect of aging on myocardial perfusion reserve. J Nucl Med 1995;36:2032-6.PubMed Uren NG, Camici PG, Melin JA, Bol A, de Bruyne B, Radvan J, et al. Effect of aging on myocardial perfusion reserve. J Nucl Med 1995;36:2032-6.PubMed
Metadata
Title
Incremental prognostic value of coronary flow reserve assessed with single-photon emission computed tomography
Authors
Robert A. deKemp, PhD
Mikael Trottier, MD, FRCPC
Rob S. B. Beanlands, MD, FACC, FRCPC
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 4/2011
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-011-9408-6

Other articles of this Issue 4/2011

Journal of Nuclear Cardiology 4/2011 Go to the issue

JOURNAL OF NUCLEAR CARDIOLOGY NEWS UPDATE

Advancing the research mission of ASNC